Ancestim Completed Phase 2 Trials for Multiple Myeloma (MM) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00001750Comparing Treatments for Multiple Myeloma